Monthly Archives: juillet 2016

Poursuite de l’étude de phase 1/1b de TG1050 de Transgene dans l’hépatite B chronique suite à la recommandation positive du Comité d’Évaluation de la Sécurité

20160721 - Safety TG1050 FR Vdef

By alcyon|2016-07-21T18:00:56+02:00juillet 21st, 2016|Communiqué de presse, TG1050|Commentaires fermés

Improvement of MVA-based Vaccines by Expression of an Autophagy Inhibitor

Anita Spindler, et al. XXI International Poxvirus, Asfavirus and Iridovirus [...]

By alcyon|2019-07-02T14:57:34+02:00juillet 1st, 2016|Publication|Commentaires fermés

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death-1 (PD-1) allow their intratumoral delivery and an improved tumor growth inhibition

Jean Baptiste Marchand, et al. XXI International Poxvirus, Asfavirus and [...]

By alcyon|2019-07-02T14:28:53+02:00juillet 1st, 2016|Invir.IO, Non classifié(e), Publication|Commentaires fermés

Evaluation of a novel oncolytic Raccoonpox virus expressing the bifunctional FCU1 suicide gene

Marine Ricordel, et al. XXI International Poxvirus, Asfavirus and Iridovirus [...]

By alcyon|2019-07-02T14:23:25+02:00juillet 1st, 2016|Publication|Commentaires fermés

Oncolytic vaccinia virus TG6002 demonstrates potent efficiency in pancreatic tumor alone and in combination with standard chemotherapies

Johann Foloppe, et al. XXI International Poxvirus, Asfavirus and Iridovirus [...]

By alcyon|2019-07-02T14:08:54+02:00juillet 1st, 2016|Publication, TG6002|Commentaires fermés